A detailed history of State Of New Jersey Common Pension Fund D transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 106,121 shares of BMRN stock, worth $8.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
106,121
Previous 108,501 2.19%
Holding current value
$8.73 Million
Previous $10.5 Million 11.4%
% of portfolio
0.03%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$83.81 - $99.0 $199,467 - $235,620
-2,380 Reduced 2.19%
106,121 $9.27 Million
Q3 2023

Nov 08, 2023

SELL
$85.07 - $94.48 $270,522 - $300,446
-3,180 Reduced 2.85%
108,501 $9.6 Million
Q2 2023

Aug 02, 2023

BUY
$86.68 - $100.3 $241,143 - $279,034
2,782 Added 2.55%
111,681 $9.68 Million
Q1 2022

May 03, 2022

SELL
$74.28 - $92.69 $223,954 - $279,460
-3,015 Reduced 2.69%
108,899 $8.4 Million
Q4 2021

Jan 31, 2022

BUY
$71.72 - $91.47 $234,667 - $299,289
3,272 Added 3.01%
111,914 $9.89 Million
Q3 2021

Oct 27, 2021

BUY
$74.77 - $85.47 $90,396 - $103,333
1,209 Added 1.13%
108,642 $8.4 Million
Q2 2021

Jul 23, 2021

SELL
$75.51 - $84.79 $353,839 - $397,325
-4,686 Reduced 4.18%
107,433 $8.96 Million
Q1 2021

Apr 27, 2021

SELL
$74.73 - $90.69 $516,309 - $626,577
-6,909 Reduced 5.8%
112,119 $8.47 Million
Q4 2020

Feb 03, 2021

SELL
$72.61 - $90.2 $559,823 - $695,442
-7,710 Reduced 6.08%
119,028 $10.4 Million
Q3 2020

Oct 27, 2020

SELL
$71.87 - $131.03 $163,001 - $297,176
-2,268 Reduced 1.76%
126,738 $9.64 Million
Q2 2020

Aug 04, 2020

SELL
$79.55 - $124.22 $492,414 - $768,921
-6,190 Reduced 4.58%
129,006 $15.9 Million
Q4 2019

Jan 31, 2020

SELL
$64.27 - $86.37 $552,979 - $743,127
-8,604 Reduced 5.98%
135,196 $11.4 Million
Q3 2019

Oct 23, 2019

BUY
$67.4 - $85.11 $9.69 Million - $12.2 Million
143,800 New
143,800 $9.69 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.